115 related articles for article (PubMed ID: 9218708)
1. Substance P and epibatidine-evoked catecholamine release from fractionated chromaffin cells.
Krause W; Michael N; Lübke C; Livett BG; Oehme P
Eur J Pharmacol; 1997 Jun; 328(2-3):249-54. PubMed ID: 9218708
[TBL] [Abstract][Full Text] [Related]
2. Catecholamine release from fractionated chromaffin cells.
Krause W; Michael N; Lübke C; Livett BG; Oehme P
Eur J Pharmacol; 1996 Apr; 302(1-3):223-8. PubMed ID: 8791011
[TBL] [Abstract][Full Text] [Related]
3. Antagonism of nicotinic receptors of rat chromaffin cells by N,N, N-trimethyl-1-(4-trans-stilbenoxy)-2-propylammonium iodide: a patch clamp and ligand binding study.
Di Angelantonio S; Nistri A; Moretti M; Clementi F; Gotti C
Br J Pharmacol; 2000 Apr; 129(8):1771-9. PubMed ID: 10780985
[TBL] [Abstract][Full Text] [Related]
4. Characterization of [(3)H]epibatidine binding to nicotinic receptors from bovine adrenal medulla.
McKay DB; Free RB; Kaser DJ; McKay SB
Ann N Y Acad Sci; 2002 Oct; 971():162-4. PubMed ID: 12438112
[No Abstract] [Full Text] [Related]
5. Receptors and receptor modulation in cultured chromaffin cells.
Livett BG; Boksa P
Can J Physiol Pharmacol; 1984 Apr; 62(4):467-76. PubMed ID: 6203633
[TBL] [Abstract][Full Text] [Related]
6. Neurotransmitter release from bovine adrenal chromaffin cells is modulated by capacitative Ca(2+)entry driven by depleted internal Ca(2+)stores.
Zerbes M; Clark CL; Powis DA
Cell Calcium; 2001 Jan; 29(1):49-58. PubMed ID: 11133355
[TBL] [Abstract][Full Text] [Related]
7. Nicotinic receptor activation by epibatidine induces heme oxygenase-1 and protects chromaffin cells against oxidative stress.
Egea J; Rosa AO; Cuadrado A; García AG; López MG
J Neurochem; 2007 Sep; 102(6):1842-1852. PubMed ID: 17540012
[TBL] [Abstract][Full Text] [Related]
8. Epibatidine: a nicotinic acetylcholine receptor agonist releases monoaminergic neurotransmitters: in vitro and in vivo evidence in rats.
Sacaan AI; Menzaghi F; Dunlop JL; Correa LD; Whelan KT; Lloyd GK
J Pharmacol Exp Ther; 1996 Feb; 276(2):509-15. PubMed ID: 8632316
[TBL] [Abstract][Full Text] [Related]
9. Evidence for spare nicotinic acetylcholine receptors and a beta 4 subunit in bovine adrenal chromaffin cells: studies using bromoacetylcholine, epibatidine, cytisine and mAb35.
Wenger BW; Bryant DL; Boyd RT; McKay DB
J Pharmacol Exp Ther; 1997 May; 281(2):905-13. PubMed ID: 9152400
[TBL] [Abstract][Full Text] [Related]
10. Brain cyclooxygenase and prostanoid TP receptors are involved in centrally administered epibatidine-induced secretion of noradrenaline and adrenaline from the adrenal medulla in rats.
Shimizu T; Yokotani K
Eur J Pharmacol; 2009 Mar; 606(1-3):77-83. PubMed ID: 19374850
[TBL] [Abstract][Full Text] [Related]
11. Substance P protects against desensitization of the nicotinic response in isolated adrenal chromaffin cells.
Boksa P; Livett BG
J Neurochem; 1984 Mar; 42(3):618-27. PubMed ID: 6198467
[TBL] [Abstract][Full Text] [Related]
12. Surface and intracellular nicotinic receptors expressed in intact adrenal chromaffin cells: direct measurements using [3H]epibatidine.
Free RB; McKay DB
Brain Res; 2003 Jun; 974(1-2):60-9. PubMed ID: 12742624
[TBL] [Abstract][Full Text] [Related]
13. Cotinine binding to nicotinic acetylcholine receptors in bovine chromaffin cell and rat brain membranes.
Vainio PJ; Tuominen RK
Nicotine Tob Res; 2001 May; 3(2):177-82. PubMed ID: 11403732
[TBL] [Abstract][Full Text] [Related]
14. Interaction of the catecholamine release-inhibitory peptide catestatin (human chromogranin A(352-372)) with the chromaffin cell surface and Torpedo electroplax: implications for nicotinic cholinergic antagonism.
Taupenot L; Mahata SK; Mahata M; Parmer RJ; O'Connor DT
Regul Pept; 2000 Nov; 95(1-3):9-17. PubMed ID: 11062327
[TBL] [Abstract][Full Text] [Related]
15. Metorphamide, a novel endogenous adrenal opioid peptide, inhibits nicotine-induced secretion from bovine adrenal chromaffin cells.
Marley PD; Mitchelhill KI; Livett BG
Brain Res; 1986 Jan; 363(1):10-7. PubMed ID: 3947946
[TBL] [Abstract][Full Text] [Related]
16. The substance P receptor subtype modulating catecholamine release from adrenal chromaffin cells.
Boksa P; Livett BG
Brain Res; 1985 Apr; 332(1):29-38. PubMed ID: 2581649
[TBL] [Abstract][Full Text] [Related]
17. Characterization of two chromaffin cell populations isolated from bovine adrenal medulla.
Moro MA; Garcia AG; Langley OK
J Neurochem; 1991 Aug; 57(2):363-9. PubMed ID: 2072090
[TBL] [Abstract][Full Text] [Related]
18. Dopamine release from bovine adrenal medullary cells in culture.
Boksa P
J Auton Nerv Syst; 1990 Apr; 30(1):63-74. PubMed ID: 1693390
[TBL] [Abstract][Full Text] [Related]
19. Enhanced antinociception by nicotinic receptor agonist epibatidine and adrenal medullary transplants in the spinal subarachnoid space.
Caban AJ; Hama AT; Lee JW; Sagen J
Neuropharmacology; 2004 Jul; 47(1):106-16. PubMed ID: 15165838
[TBL] [Abstract][Full Text] [Related]
20. Possible inhibitory role of endogenous 2-arachidonoylglycerol as an endocannabinoid in (±)-epibatidine-induced activation of central adrenomedullary outflow in the rat.
Shimizu T; Tanaka K; Shimizu S; Higashi Y; Yawata T; Nakamura K; Taniuchi K; Ueba T; Yuri K; Saito M
Neuropharmacology; 2015 Aug; 95():278-89. PubMed ID: 25882827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
